Incyte reports Q3 revenue increase and raises 2026 guidance
Total revenue reached $1.56 billion. Incyte acquired Vega Therapeutics and advanced pipeline programs in oncology and hematology.
Latest Incyte News & Updates
See the latest news and media coverage for Incyte. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biopharmaceutical company developing medicines for serious diseases
incyte.com- Headquarters
- Wilmington, United States
- Company type
- Public company
- Number of employees
- 3,500–5,000
- Industry
- Pharmaceuticals
Last updated
Latest news about Incyte
In short: Incyte partnered with Genmab on colorectal cancer and presented solid tumor data at ESMO 2026.
Company announcements
Incyte reports Q3 2026 revenue growth
Total revenue reached $1.56B, up 14%. Net sales hit $1.32B, driven by Opzelura and hematology products. FY2026 guidance remains unchanged.
Incyte announces strong 2023 financial results and pipeline updates
Revenue grew 14% to $3.7 billion. The company highlights Opzelura sales growth and regulatory milestones for axatilimab.
Incyte announces FDA approval for Atebrioz in partnership with Mirum
The once-daily oral ALK2 inhibitor treats heterotopic ossification in patients aged 12 and older. Commercial availability is expected in October.
Media coverage
Incyte’s (NASDAQ:INCY) Q3 2026 sales beat estimates but full-year sales guidance misses expectations significantly
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported revenue ahead of Wall Street’s expectations in Q3 2026, ...
Incyte (INCY) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Incyte (INCY) give a sense of how its business performed in the quarter ended September 2026, it might be...
Incyte stock follows strong Q2 figures
Incyte stock benefits from a strong second quarter of 2026 with $1.67 billion in revenue and $3.09...
Incyte stock gains as latest results highlight double digit revenue growth
Incyte stock is trading higher as investors digest double digit revenue growth and updated guidance from the biotech company, with the latest quarterly figures and...
Never miss news about Incyte
Track Incyte and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Incyte competitors & trending companies
Browse news for competitors to Incyte and other trending companies.
AstraZeneca
Novartis
Biogen
Pfizer
Merck
Ipsen
argenx
Gilead
Amgen
GSK
MSD
Jazz
Sanofi
Genmab
BMS
AbbVie
Regeneron
Insmed
Blueprint Medicines
Zymeworks
UCB
SharkNinja
NRx
Ropes & Gray
HighTech Kaunas
inretrn
Poundland
Farrer & Co
Specialfastigheter
SISAB
Hemsö
Stenvalvet
Liljewall
Veidekke
Locum
NCC